UPTRAVI
NDC 66215-616, Selexipag, tablet, coated, from Actelion Pharmaceuticals US, Inc..
- Product NDC
- 66215-616
- Status
- Listed
- Labeler
- Actelion Pharmaceuticals US, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207947
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66215-616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SELEXIPAG1600 ug/1
Pharmacologic classes
Prostacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66215-616-06 | 66215061606 | 1 BOTTLE in 1 CARTON (66215-616-06) / 60 TABLET, COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a7a23b87-f892-4e2c-8e2e-ebf841220f90
Use it
Look up 66215-616 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66215-616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66215-616. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.